Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of Hexaxim in healthy Chinese infants
CTR20262703Phase 3Active
- Sponsor
- ---/ 深圳赛诺菲巴斯德生物制品有限公司
- Start
- Jul 2026
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of hexaxim in diphtheria, Tetanus, pertussis, poliomyelitis, hepatitis B (HBV), sponsored by ---/ 深圳赛诺菲巴斯德生物制品有限公司. Started Jul 2026; status: active.
02
Drugs
hexaxim
03
Conditions
diphtheriaTetanuspertussispoliomyelitishepatitis B (HBV)
Beyond the preview
Go deeper on CTR20262703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262703.